您好,欢迎来到佐思信息
全国服务热线:
400-009-0050
佐思信息专注支持企业决策

联系我们

400-009-0050

北京热线:010-82863481
13436696826
上海热线:021-64871266
021-64872612
传 真: 010-82601570
021-64872324

您当前的位置:首页>>研究报告>>生物科技综合

全球神经调节设备市场2013-2023研究报告
Neuromodulation Devices: World Market Prospects 2013-2023

全球神经调节设备市场2013-2023研究报告
【报告编号】:No.2684
【发布时间】:2013-01
【关 键 字】:神经调节   Neuromodulation   
【报告页数】:125页
【报告价格】:电子版:1549英镑
【交付方式】:Email发送或EMS快递
【订购热线】:


400-009-0050(全国24小时服务)
北京:010-82863481 13436696826
上海:021-64871266 021-64872612

报告目录下载订购协议下载在线咨询

    专业、专注于为企业提供真正有价值的全球市场调查信息,是我们的使命。我们是中国第一家汇集全球众多行业研究机构研究成果的平台,致力于为企业决策提供最有效的市场资讯,特别是为中国企业了解和进入国际市场迈出第一步,提供全面的信息参考,我们跨越语言及时间的障碍,在信息爆炸的当下,努力为客户提供最有价值的全球产业资讯。我们公司也拥有独立的研究机构,聚焦于中国市场的研究,为国内外企业在中国市场大展宏图提供市场研究支持。

• 我们在全球的合作伙伴>>• 我们的研究中心>>

  • 英文摘要
  • 中文摘要
  • 索取简版报告
  • 生物科技综合行业的相关报告

Abstract

Neuromodulation is one of the fastest growing sectors of the medical device market. Neuromodulation is a rapidly evolving medical technique that provides symptomatic relief through the alteration, or modulation, of nerve system function. It works by either stimulating nerves to produce a natural biological response or by applying small doses of pharmaceutical agents directly to the site of action.
The market has significant potential for growth with the increasing global burden of neurological and cardiovascular disorders, especially in the emerging economies. The growth in emerging markets such as India and China will be driven by an aging population that will increase demand for newer treatment options for age-related diseases. India's expanding economy is likely to see an increased wealth among the population, specifically within the middle class, which will cause an increased adoption of westernised lifestyles. Diseases such as obesity and coronary heart disease will therefore become more prevalent. The neuromodulation devices market in the emerging economies will also benefit from a rise in demand for non-invasive treatment options and medical tourism. Growth in this market will also be driven by the approval and launch of neuromodulation devices that are more effective and involve a more simplified, less-invasive implantation procedure.
Neuromodulation Devices: World Market Prospects 2013-2023 analyses the top 4 companies involved in the neuromodulation devices market. This report also provides sales forecasts, market share analyses, discussions of technological developments and analyses of commercial drivers and restraints, including SWOT analysis of the overall neuromodulation devices market. There are 75 tables and figures included. The result is comprehensive profiles on the leading companies operating in the neuromodulation devices market with detailed analyses and informed opinion to benefit your work. Visiongain has determined that the value of the global Neuromodulation Devices Market will reach $12.45bn in 2023.

What makes this report unique?

Visiongain consulted widely with industry experts and full transcripts from these exclusive interviews are included in the report. As such, our reports have a unique blend of primary and secondary sources providing informed opinion. The report provides insight into key drivers and restraints facing the industry, as well as identifying leading companies. The report also provides a unique blend of qualitative analysis combined with extensive quantitative data including global, submarket and national market forecasts from 2012-2023 - all highlighting key business opportunities.

Why you should buy Neuromodulation Devices: World Market Prospects 2013-2023

  • 111 pages of comprehensive analysis
  • 2 Exclusive Visiongain interviews with experts from-
    • Cochlear Ltd
    • a US-based Medical Device Company (views provided anonymously)
  • 75 tables, charts, and graphs
  • Neuromodulation Device market forecasts between 2012-2023
  • 3 Neuromodulation Device submarket forecasts from 2012-2023
    • Spinal Cord Stimulation (SCS)
    • Deep Brain Stimulation (DBS)
    • Vagus Nerve Stimulation (VNS)
  • A SWOT analysis
  • Several leading companies identified and 4 profiled -
    • Medtronic
    • St. Jude Medical
    • Boston Scientific
    • Cyberonics

You can order this report today

Gain an understanding of the overall neuromodulation devices market and the leading companies operating in this market by ordering Neuromodulation Devices: World Market Prospects 2013-2023.
Visiongain is a trading partner with the US Federal Government.

Table of Contents

1. Executive Summary

  • 1.1. Sector Highlights
  • 1.2. Aim, Scope and Format of the Report
  • 1.3. Chapter Outline
  • 1.4. Research and Analysis Method
  • 1.5. Glossary of Terms Related to the Report

2. An Introduction to Neuromodulation

  • 2.1. Neuromodulation
  • 2.2. Techniques Used in Neuromodulation
    • 2.2.1. Electrical Stimulation Techniques
      • 2.2.1.1. Brain and Spinal Cord Therapies
      • 2.2.1.2. Cranial Nerve Stimulation
      • 2.2.1.3. Functional Electrical Stimulation
    • 2.2.2. Pharmacological Therapy
  • 2.3. Application of Neuromodulation
    • 2.3.1. Pain
      • 2.3.1.1. Neuromodulation in The Management of Pain
    • 2.3.2. Depression
      • 2.3.2.1. Neuromodulation in The Management of Depression
    • 2.3.3. Epilepsy
      • 2.3.3.1. Neuromodulation in The Management of Epilepsy
    • 2.3.4. Urological Disorders: Overactive Bladder & Urinary Incontinence
      • 2.3.4.1. Neuromulation in The Management of Urinary Incontinence
    • 2.3.5. Hearing Disorders: Profound Deafness
      • 2.3.5.1. Neuromodulation in The Management of Impaired Hearing
    • 2.3.6. Cardiac Disorders: Arrhythmias & Angina
      • 2.3.6.1. Neuromodulation in The Management of Cardiac Disorders
    • 2.3.7. Parkinson's Disease
      • 2.3.7.1. Neuromodulation in The Management of Parkinson's Disease

3. The Global Neuromodulation Devices Market, 2011-2023

  • 3.1. The Global Medical Device Market, 2011
    • 3.1.1. The Global Neurology Devices Market, 2011
  • 3.2. The Global Neuromodulation Devices Market, 2011
  • 3.3. The Global Neuromodulation Devices Market Forecast, 2013-2023
  • 3.4. Neuromodulation Devices: Industry Trends, 2013-2023

4. Neuromodulation Devices Market Sectors: Spinal Cord Stimulation

  • 4.1. Spinal Cord Stimulation (SCS)
  • 4.2. SCS Market Forecast, 2013-2023
  • 4.3. Spinal Cord Stimulation: Industry Trends, 2013-2023
  • 4.4. Companies and Products
    • 4.4.1. Medtronic
    • 4.4.2. Boston Scientific
    • 4.4.3. St. Jude Medical (SJM)
    • 4.4.4. Nevro

5. Neuromodulation Devices Market Sectors: Deep Brain Stimulation

  • 5.1. Deep Brain Stimulation (DBS)
  • 5.2. DBS Market Forecast, 2013-2023
  • 5.3. Deep Brain Stimulation: Industry Trends, 2013-2023
  • 5.4. Companies and Products
    • 5.4.1. Medtronic
    • 5.4.2. St. Jude Medical

6. Neuromodulation Devices Market Sectors: Vagus Nerve Stimulation

  • 6.1. Vagus Nerve Stimulation (VNS)
  • 6.2. VNS Market Forecast, 2013-2023
  • 6.3. Vagus Nerve Stimulation: Industry Trends, 2013-2023
  • 6.4. Companies and Products
    • 6.4.1. Cyberonics
    • 6.4.2. CerebralRx (a spin-off of BioControl Medical)
    • 6.4.3. EnteroMedics

7. The Leading Neuromodulation Device Manufacturers, 2011

  • 7.1. Few Players Dominate the Market
  • 7.2. Neuromodulation Device Market: Breakdown By Company, 2011
  • 7.3. Medtronic
    • 7.3.1. Sales and Recent Performance Analysis, 2011
      • 7.3.1.1. Restorative Therapies
    • 7.3.2. Medtronic Geographic Sales
    • 7.3.3. Medtronic News
      • 7.3.3.1. Expanding Into Sacral Neuromodulation
      • 7.3.3.2. Adaptive Spinal Neuromodulation
  • 7.4. St. Jude Medical (SJM)
    • 7.4.1. Sales and Recent Performance Analysis, 2011
      • 7.4.1.1. Cardiac Rhythm Management/Neuromodulation (CRM/NMD)
    • 7.4.2. SJM Geographic Sales
    • 7.4.3. SJM News
      • 7.4.3.1. Peripheral Nerve Stimulation (PNS)
  • 7.5. Boston Scientific
    • 7.5.1. Sales and Recent Performance Analysis, 2011
    • 7.5.2. Boston Scientific Geographic Sales
    • 7.5.3. Boston Scientific News
      • 7.5.3.1. Advancements in Deep Brain Stimulation (DBS) Technology
  • 7.6. Cyberonics
    • 7.6.1. Sales and Recent Performance Analysis, 2011
    • 7.6.2. Cyberonics Geographic Sales
    • 7.6.3. Cyberonics News
      • 7.6.3.1. Strengthening VNS Technology Through Investment
  • 7.7. Other Neuromodulation Device Manufacturers

8. Leading National Neuromodulation Devices Market, 2013-2023

  • 8.1. Regional Breakdown of The Global Neuromodulation Devices Market, 2011
  • 8.2. The Global Neuromodulation Devices Market: Regional Forecast, 2011-2023
  • 8.3. The US Market
  • 8.4. The European Market
    • 8.4.1. Germany
    • 8.4.2. France
    • 8.4.3. Italy
    • 8.4.4. Spain
    • 8.4.5. UK
  • 8.5. The Japanese Market
  • 8.6. The Chinese Market
  • 8.7. The Indian Market

9. Neuromodulation Devices Market: Industry Pipeline

  • 9.1. Innovative Technology Drives the Market
  • 9.2. Apnex Medical
  • 9.3. CVRx
  • 9.4. EnteroMedics
  • 9.5. ImThera Medical
  • 9.6. Intelect Medical (acquired by Boston Scientific Corporation)
  • 9.7. MetaCure
  • 9.8. NeuroPace

10. SWOT Analysis of The Neuromodulation Devices Market, 2011

  • 10.1. Neuromodulation Devices: Industry Trends
  • 10.2. Strengths
    • 10.2.1. Safer Alternative
    • 10.2.2. Cost Effective
    • 10.2.3. Less Medication
  • 10.3. Weaknesses
    • 10.3.1. Mechanisms Are Not Well Understood
    • 10.3.2. Market Dominated by Small Number of Large Companies
    • 10.3.3. FDA Approvals
    • 10.3.4. Failing Clinical Trials
  • 10.4. Opportunities
    • 10.4.1. Expanding Disease Indications
    • 10.4.2. Increasing Prevalence of Neurological Diseases
    • 10.4.3. The Potential of Personalised Medicine
    • 10.4.4. Expansion into Emerging Markets
  • 10.5. Threats
    • 10.5.1. Emergence of Stem Cells
    • 10.5.2. SCS Faces Competition from Other Treatment Options
    • 10.5.3. Increasing Regulatory Scrutiny

11. Opinions from Our Industry Survey

  • 11.1. Interview with Spokesperson From Medical Device Company
    • 11.1.1. The Cochlear Implant Market
    • 11.1.2. Cochlear Implant Technology
    • 11.1.3. Products and Competition
    • 11.1.4. Future Cochlear Implant Market
  • 11.2. Interview with Mr. Martin Dobelle, Avery Biomedical
    • 11.2.1. The Neuromodulation Devices Market
    • 11.2.2. Phrenic Nerve Stimulation & The Breathing Pacemaker System
    • 11.2.3. Patient Perception and Regulation
    • 11.2.4. Future Projections for The Neuromodulation Devices Market

12. Conclusions

  • 12.1. Overview
  • 12.2. Spinal Cord Stimulation will Remain the Largest Segment
  • 12.3. Prominent Companies in The Market
  • 12.4. World Market Forecasts
  • 12.5. Future Outlook and Concluding Remarks

Appendix A

  • About Visiongain

Appendix B

  • Visiongain report evaluation form

List of Tables

  • Table 3.1: Net Sales ($bn) and Market Shares (%) Of The Global Medical Market, By Sector, 2011
  • Table 3.2: The Global Neurology Devices Market: Net Sales ($bn) and Market Shares (%), By Speciality, 2011
  • Table 3.3: The Global Neuromodulation Devices Market: Net Sales ($bn) and Market Shares (%), By Technology, 2011
  • Table 3.4: The Global Neuromodulation Devices Market Forecast, By Sector ($bn), 2011-2017
  • Table 3.5: The Global Neuromodulation Devices Market Forecast, By Sector ($bn), 2017-2023
  • Table 4.1: Spinal Cord Stimulation: Market Forecast ($bn), 2011-2017
  • Table 4.2: Spinal Cord Stimulation: Market Forecast ($bn), 2017-2023
  • Table 5.1: Deep Brain Stimulation: Market Forecast ($bn), 2011-2017
  • Table 5.2: Deep Brain Stimulation: Market Forecast ($bn), 2017-2023
  • Table 6.1: Vagus Nerve Stimulation: Market Forecast ($bn), 2011-2017
  • Table 6.2: Vagus Nerve Stimulation: Market Forecast ($bn), 2017-2023
  • Table 7.1: Neuromodulation Devices: Net Sales ($bn) and Market Shares (%), By Company, 2011
  • Table 7.2: Medtronic: Net Sales ($bn) and Market Shares (%), By Segment, 2011
  • Table 7.3: Restorative Therapies: Net Sales ($bn) and Market Shares (%), By Product Line, 2011
  • Table 7.4: Medtronic: Net Sales ($bn) and Market Shares (%), By Region, 2011
  • Table 7.5: SJM: Net Sales ($bn) and Market Shares (%), By Segment, 2011
  • Table 7.6: CRM/NMD Segment: Net Sales ($bn) and Market Shares (%), By Product Group, 2011
  • Table 7.7: SJM: Net Sales ($bn) and Market Shares (%), By Region, 2011
  • Table 7.8: Boston Scientific: Net Sales ($bn) and Market Shares (%), By Product Category, 2011
  • Table 7.9: Boston Scientific: Net Sales ($bn) and Market Shares (%), By Region, 2011
  • Table 7.10: Cyberonics: Net Sales ($m) and Market Shares (%), By Region, 2011
  • Table 7.11: Other Companies Operating in The Global Neuromodulation Device Market, 2012
  • Table 8.1: Neuromodulation Devices: Sales ($bn) and Market Shares (%), By Country/Region, 2011
  • Table 8.2: Neuromodulation Devices Market Forecast ($bn), By Country/Region, 2011-2023
  • Table 8.3: The Leading European Neuromodulation Devices Markets: Market Value ($bn), European Market Shares (%) and Global Market Shares (%), By Region, 2011
  • Table 8.4: The European Neuromodulation Devices Market Forecast ($bn), By Region, 2011-2023
  • Table 9.1: Neuromodulation Devices: Industry Pipeline, 2012
  • Table 10.1: SWOT Analysis of the Neuromodulation Devices Market, 2012
  • Table 12.1: Neuromodulation Devices Market Forecast ($bn) By Technology, in 2017, 2019 and 2023

List of Figures

  • Figure 3.1: Market Shares (%) Of The Global Medical Device Market, By Sector, 2011
  • Figure 3.2: The Global Neurology Devices Market: Market Shares (%), By Speciality, 2011
  • Figure 3.3: The Global Neuromodulation Devices Market: Net Sales ($bn), By Technology, 2011
  • Figure 3.4: The Global Neuromodulation Devices Market: Market Shares (%), By Technology, 2011
  • Figure 3.5: The Global Neuromodulation Devices Market Forecast, 2011-2017
  • Figure 3.6: The Global Neuromodulation Devices Market Forecast, 2017-2023
  • Figure 4.1: Spinal Cord Stimulation: Market Forecast ($bn), 2011-2017
  • Figure 4.2: Spinal Cord Stimulation: Market Forecast ($bn), 2017-2023
  • Figure 5.1: Deep Brain Stimulation: Market Forecast ($bn), 2011-2017
  • Figure 5.2: Deep Brain Stimulation: Market Forecast ($bn), 2017-2023
  • Figure 6.1: Vagus Nerve Stimulation: Market Forecast ($bn), 2011-2017
  • Figure 6.2: Vagus Nerve Stimulation: Market Forecast ($bn), 2017-2023
  • Figure 7.1: Neuromodulation Devices: Net Sales ($bn), By Company, 2011
  • Figure 7.2: Neuromodulation Devices: Market Shares (%), By Company, 2011
  • Figure 7.3: Medtronic: Market Shares (%), By Segment, 2011
  • Figure 7.4: Restorative Therapies: Net Sales ($bn), By Product Line, 2011
  • Figure 7.5: Restorative Therapies: Market Shares (%), By Product Line, 2011
  • Figure 7.6: Medtronic: Net Sales ($bn), By Region, 2011
  • Figure 7.7: Medtronic: Market Shares (%), By Region, 2011
  • Figure 7.8: SJM: Market Shares (%), By Segment, 2011
  • Figure 7.9: CRM/NMD Segment: Market Shares (%), By Product Group, 2011
  • Figure 7.10: SJM: Net Sales ($bn), By Region, 2011
  • Figure 7.11: SJM: Market Shares (%), By Region, 2011
  • Figure 7.12: Boston Scientific: Net Sales ($bn), By Product Category, 2011
  • Figure 7.13: Boston Scientific: Market Shares (%), By Product Category, 2011
  • Figure 7.14: Boston Scientific: Net Sales ($bn), By Region, 2011
  • Figure 7.15: Boston Scientific: Market Shares (%), By Region, 2011
  • Figure 7.16: Cyberonics: Net Sales ($m), By Quarter, 2011
  • Figure 7.17: Cyberonics: Net Sales ($m), By Region, 2011
  • Figure 7.18: Cyberonics: Market Shares (%), By Region, 2011
  • Figure 8.1: Neuromodulation Devices: Net Sales ($bn), By Region, 2011
  • Figure 8.2: Neuromodulation Devices: Market Shares (%), By Region, 2011
  • Figure 8.3: The US Neuromodulation Devices Market Forecast ($bn), 2011-2023
  • Figure 8.4: The European Neuromodulation Devices Market: Net Sales ($bn), By Region, 2011
  • Figure 8.5: The European Neuromodulation Devices Market: Market Shares (%), By Region, 2011
  • Figure 8.6: The European Neuromodulation Devices Market Forecast ($bn), 2011-2023
  • Figure 8.7: The German Neuromodulation Devices Market Forecast ($bn), 2011-2023
  • Figure 8.8: The French Neuromodulation Devices Market Forecast ($bn), 2011-2023
  • Figure 8.9: The Italian Neuromodulation Devices Market Forecast ($bn), 2011-2023
  • Figure 8.10: The Spanish Neuromodulation Devices Market Forecast ($bn), 2011-2023
  • Figure 8.11: The UK Neuromodulation Devices Market Forecast ($bn), 2011-2023
  • Figure 8.12: The Japanese Neuromodulation Devices Market Forecast ($bn), 2011-2023
  • Figure 8.13: The Chinese Neuromodulation Devices Market Forecast ($bn), 2011-2023
  • Figure 8.14: The Indian Neuromodulation Devices Market Forecast ($bn), 2011-2023
  • Figure 12.1: Projected Neuromodulation Devices Market Size for 2017, 2019 and 2023, By Technology
  • Figure 12.2: Projected Total Neuromodulation Devices Market Size ($bn) in 2011, 2017, 2019 and 2023

Companies Listed

  • Advanced Bionics
  • Aleva Neurotherapeutics
  • Apnex Medical
  • Atrotech
  • Autonomic Technologies
  • Avery Biomedical
  • BioControl Medical
  • Boston Scientific
  • Cerbomed
  • Cervel Neurotech
  • CVRx
  • Cyberonics
  • ElectroCore
  • EnteroMedics
  • Functional Neuromodulation
  • ImThera Medical
  • Inspire Medical Systems
  • Intelect Medical
  • IntraPace
  • Med-El
  • Medtronic
  • MetaCure
  • MicroTransponder
  • Neurelec
  • Neuronetics
  • Neuronix Medical
  • NeuroPace
  • Neuros Medical
  • Neurosigma
  • Neurotech Group
  • Neurowave Medical Technologies
  • Nevro
  • Respicardia
  • Retina Implant AG
  • RS Medical/Vertis Neuroscience
  • Second Sight Medical Products
  • Spinal Modulation
  • SPR Therapeutics
  • St. Jude Medical
  • Synapse Biomedical
  • Uroplasty

Government Agencies and Other Organisations Mentioned in This Report

  • FDA
  • WHO
  • UN
  • EU

关于我们|联系我们|常见问题|服务项目|购买流程
2005-2013 All rights reserved.京ICP备05069564号-4 京公网安备110108 02010359号
全国服务热线:400-009-0050北京:010-82863481上海:021-64871266

在线客服系统